| Autor: |
Raftery LJ; Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Brisbane, Australia. m.trau@uq.edu.au., Howard CB; Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Brisbane, Australia. m.trau@uq.edu.au and Centre for Personalised Nanomedicine, AIBN, University of Queensland, Brisbane, Australia and ARC Training Centre for Biopharmaceutical Innovation, AIBN, University of Queensland, Brisbane, Australia., Grewal YS; Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Brisbane, Australia. m.trau@uq.edu.au and Centre for Personalised Nanomedicine, AIBN, University of Queensland, Brisbane, Australia., Vaidyanathan R; Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Brisbane, Australia. m.trau@uq.edu.au and Centre for Personalised Nanomedicine, AIBN, University of Queensland, Brisbane, Australia., Jones ML; Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Brisbane, Australia. m.trau@uq.edu.au and ARC Training Centre for Biopharmaceutical Innovation, AIBN, University of Queensland, Brisbane, Australia., Anderson W; Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Brisbane, Australia. m.trau@uq.edu.au and Centre for Personalised Nanomedicine, AIBN, University of Queensland, Brisbane, Australia., Korbie D; Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Brisbane, Australia. m.trau@uq.edu.au and Centre for Personalised Nanomedicine, AIBN, University of Queensland, Brisbane, Australia., Duarte T; Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia., Cao MD; Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia., Nguyen SH; Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia., Coin LJM; Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia., Mahler SM; Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Brisbane, Australia. m.trau@uq.edu.au and ARC Training Centre for Biopharmaceutical Innovation, AIBN, University of Queensland, Brisbane, Australia., Trau M; Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Brisbane, Australia. m.trau@uq.edu.au and Centre for Personalised Nanomedicine, AIBN, University of Queensland, Brisbane, Australia and School of Chemistry and Molecular Biosciences (SCMB), University of Queensland, Brisbane, Australia. |
